MicroPort® Organizes “Belt and Road” International PCI Symposium at CIT Online 2020

Beijing, China, December 17, 2020 — Shanghai MicroPort Medical (Group) Co., Ltd. (MicroPort®), together with experts from five countries, successfully organized CIT Online 2020, “Belt and Road” International PCI Symposium at the 10th China Interventional Therapeutics (CIT 2020). The symposium, which attracted an audience of nearly 8,000 experts and scholars from home and abroad, was part of the first-ever multi-session format at CIT 2020, held on December 5, 2020.

MicroPort® PCI products are now available in more than 30 countries along the “Belt and Road”, including Singapore, Malaysia, Indonesia and Thailand, providing integrated medical solutions for local doctors and patients in these countries. Responding to the situation that some Belt and Road countries are simply equipped with rudimentary medical equipment and have a shortage of surgeons with systematic education and training on minimally invasive surgery, MicroPort® has also launched a number of projects over the years to provide education and exchange opportunities for local doctors, disseminate the latest information and share clinical experiences.

The first half of the symposium was held by Prof. Junjie Zhang from Nanjing First Hospital. Prof. Bo Xu from Fuwai Hospital of Chinese Academy of Medical Sciences, and Secretary-General of CIT, who gave an opening speech. Prof. Doni Firman, President of the Indonesian Society of Cardiac Intervention, introduced the training system for interventional cardiologists in Indonesia, and shared cooperation and training programs, as well as fellowship programs between China and Indonesia over the years. Prof. Shixin Ma from Shanghai Sixth People’s Hospital shared a reopening procedure for a patient with severe calcified CTO using the Firehawk® stent developed by MicroPort®, which led to a lively discussion among the participating experts.

The second half of the symposium was held by Prof. Lang Li, Vice President of the First Affiliated Hospital of Guangxi Medical University and Chairman of the China-ASEAN Coronary Intervention Summit. Prof. Bin Zhang of Guangdong Provincial People’s Hospital shared the principle of ESC (efficiency, safety, and cost-effectiveness), which was derived from his long-standing experience in reverse CTO procedures. Krissada Meemook, a rising star interventionalist from Ramathibodi Hospital in Thailand, presented a complex CTO case and highly evaluated the Firehawk® stent.

“The Firehawk® stent uses the latest coating technology, which significantly reduces the coating area while allowing only the metal stent to remain in the vessel after the coating degrades. As a result, Firehawk® demonstrates excellent performance in terms of early healing and long-term safety in CTO procedures,” he commented. Further, experts from various countries shared their clinical experiences and exchanged the latest industry trends in high-level academic interactions at the forum, and both Prof. Li and Prof. Xu Bo spoke highly of the event.

In the future, MicroPort® will continue to develop an academic exchange platform for more cardiovascular interventionists and empower medical professionals from “Belt and Road” countries to master more cutting-edge treatment techniques through capacity development, which will support the development of percutaneous coronary intervention and benefit more patients worldwide.